Anagni, in fumo il progetto da 100 milioni di Catalent per la produzione di vaccini - AboutPharma
Johnson & Johnson Partnering With Bloomington Company To Help Make COVID-19 Vaccine | WBIW
Coronavirus: Catalent va accélérer la production de vaccins de Johnson & Johnson - Challenges
J&J plant authorization clears way for big boost in U.S. COVID-19 shots | Reuters
White House knew more than a week ago of J&J contractor vaccine-supply problems - POLITICO
Addio Catalent a Anagni, "burocrazia troppo lunga ci spostiamo in Gb". Persi 100 posti di lavoro - la Repubblica
The Story of the Johnson & Johnson COVID-19 Vaccine
Johnson & Johnson: The race to manufacture Covid-19 vaccines at record speed | CNN
Catalent to ramp up J&J vaccine production at Italian plant | Reuters
Catalent promotes Sharon Johnson within new organisation - PMLiVE
Accelerating Development & Manufacturing of Biologics
Why There Will Be Fewer Johnson & Johnson COVID-19 Vaccines Next Week : NPR
Azioni USA: Johnson & Johnson pattern rialzista, Catalent in rialzo del 54% nel 2023 - fxempire.it
Johnson & Johnson vaccine production problems at Emergent plant in Baltimore - The Washington Post
Catalent breaks ground at US$112m drug product manufacturing facility
Anagni – Alla Catalent dopo Astrazeneca anche Pfizer – BioNTech e Johnson & Johnson | TG24.info
Covid-19 : Catalent va produire pour Johnson & Johnson
Vaccino Johnson & Johnson sarà prodotto ad Anagni nello stabilimento Catalent - Latina24ore.it
J&J expands COVID-19 vaccine pact with Catalent for finishing work at Italian facility | Fierce Pharma
Catalent increases capacity for J&J's COVID vaccine - BioProcess InsiderBioProcess International
J&J to make up to 3 bln COVID-19 vaccines in 2022 -chief scientist | Reuters
Making and Manufacturing Johnson & Johnson's Janssen COVID-19 Vaccine
FDA authorizes J&J partner to help with vaccine production - POLITICO
